Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 208-218

  Dutra, Walderez Ornelas ^a   Menezes, Cristiane Alves Silva ^a,b   Villani, Fernanda Nobre Amaral ^a   da Costa, Germano Carneiro ^a   da Silveira, Alexandre Barcelos Morais ^c   Reis, Débora D'Ávila ^a   Gollob, Kenneth J ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Chagas disease; Immunoregulation; Pathology; Protection; T cells

Indexed keywords

EID: 68949217385     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900027     Document Type: Article

References (75)

1. Adad SJ, Andrade DC, Lopes ER, Chapadeiro E 1991. Pathological anatomy of chagasic megaesophagus. Rev Inst Med Trop São Paulo 33: 443-450.
2. Adad SJ, Cançado CG, Etchebehere RM, Teixeira VP, Gomes UA, Chapadeiro E, Lopes ER 2001. Neuron count reevaluation in the myoenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch 438: 254-258.
3. +T cells in chronic Chagas' disease patients. Int Immunol 18: 465-471.
4. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Gollob KJ 2004. Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clin Exp Immunol 136: 341-348.
5. Antonelli LR, Dutra WO, Oliveira RR, Torres KC, Guimaraes LH, Bacellar O, Gollob KJ 2006. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alphabeta and gammadelta T cells from human patients with cutaneous leishmaniasis. Infect Immun 74: 6317-6323.
6. Apt W, Arribada A, Zulantay I, Sanchez G, Vargas SL, Rodriguez J 2003. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up. Ann Trop Med Parasitol 97: 23-29.
7. Aufderheide AC, Salo W, Madden M, Streitz J, Buikstra J, Guhl F, Arriaza B, Renier C, Wittmers LE Jr, Fornaciari G, Allison M 2004. A 9,000-year record of Chagas' disease. Proc Natl Acad Sci USA 17: 2034-2039.
8. Bahia-Oliveira LM, Gomes JA, Cançado JR, Ferrari TC, Lemos EM, Luz ZM, Moreira MC, Gazzinelli G, Correa-Oliveira R 2000. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J Infect Dis 182: 634-638.
9. Beard CB, Pye G, Steurer FJ, Rodriguez R, Campman R, Peterson AT, Ramsey J, Wirtz RA, Robinson LE 2003. Chagas disease in a domestic transmission cycle, Southern Texas, USA. Emerg Infect Dis 9: 103-105.
10. Benoist C, Mathis D 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2: 797-801.
11. Benvenuti LA, Roggério A, Sambiase NV, Fiorelli A, Higuchi M de L 2005. Polymerase chain reaction in endomyocardial biopsies for monitoring reactivation of Chagas' disease in heart transplantation: a case report and review of the literature. Cardiovasc Pathol 14: 265-268.
12. Bocchi EA, Bellotti G, Mocelin AO, Uip D, Bacal F, Higuchi ML, Amato-Neto V, Fiorelli A, Stolf NA, Jatene AD, Pileggi F 1996. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg 61: 1727-1733.
13. Cardoso GM, Morato MJ, Gomes JA, Rocha MO, Bonfim IP, Williams-Blangero S, VandeBerg JL, Reis MR, Magalhães EF, Correa-Oliveira R 2006. Comparative analysis of cell phenotypes in different severe clinical forms of Chagas' disease. Front Biosci 11: 1158-1163.
14. Corbett CE, Ribeiro U Jr, Prianti MG, Habr-Gama A, Okumura M, Gama-Rodrigues J 2001. Cell-mediated immune response in megacolon from patients with chronic Chagas' disease. Dis Colon Rectum 44: 993-998.
15. Costa GC, da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ, Dutra WO 2009. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 199: 451-454.
16. Costa RP, Gollob KJ, Fonseca LL, Rocha MO, Chaves AC, Medrano-Mercado N, Araújo-Jorge TC, Antas PR, Colley DG, Correa-Oliveira R, Gazzinelli G, Carvalho-Parra J, Dutra WO 2000. T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol 51: 511-519.
17. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM 2006. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39: 41-54.
18. Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J 1996. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 98: 1709-1712.
19. da Silveira AB, Adad SJ, Correa-Oliveira R, Furness JB, D'Avila Reis D 2007a. Morphometric study of eosinophils, mast cells, macrophages and fibrosis in the colon of chronic chagasic patients with and without megacolon. Parasitology 134: 789-796.
20. da Silveira AB, Arantes RM, Vago AR, Lemos EM, Adad SJ, Correa-Oliveira R, D'Avila Reis D 2005. Comparative study of the presence of T. cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology 131: 627-634.
21. da Silveira AB, Correa-Oliveira R, Matsuyama H, de Oliveira EC, Neto SG, Luquetti AO, Furness JB, d'Avila Reis D 2008a. Decreased expression of IK channels in neurons from enteric nervous system is associated with the development of chagasic megacolon. Hum Pathol 39: 1406-1407.
22. da Silveira AB, D'Avila Reis D, de Oliveira EC, Neto SG, Luquetti AO, Poole D, Correa-Oliveira R, Furness JB 2007b. Neurochemical coding of the enteric nervous system in chagasic patients with megacolon. Dig Dis Sci 52: 2877-2883.
23. da Silveira AB, de Araújo FF, Freitas MA, Gomes JA, Chaves AT, de Oliveira EC, Neto SG, Luquetti AO, da Cunha Souza G, Bernardino Júnior R, Fujiwara R, d'Avila Reis D, Correa-Oliveira R 2009. Characterization of the presence and distribution of Foxp3(+) cells in chagasic patients with and without megacolon. Hum Immunol 70: 65-7.
24. da Silveira AB, Freitas MA, de Oliveira EC, Neto SG, Luquetti AO, Furness JB, Correa-Oliveira R, d'Avila Reis D 2008b. Neuronal plasticity of the enteric nervous system is correlated with chagasic megacolon development. Parasitology 135: 1337-1342.
25. da Silveira AB, Lemos EM, Adad SJ, Correa-Oliveira R, Furness JB, D'Avila Reis D 2007c. Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum Pathol 38: 1256-1264.
26. d'Avila Reis D, Lemos EM, Silva GC, Adad SJ, McCurley T, Correa-Oliveira R, Machado CR 2001. Phenotypic characterization of the inflammatory cells in chagasic megaoesophagus. Trans R Soc Trop Med Hyg 95: 177-178.
27. Dutra WO, Colley DG, Pinto-Dias JC, Gazzinelli G, Brener Z, Pereira ME, Coffman RL, Correa-Oliveira R, Carvalho-Parra JF 2000. Self and nonself stimulatory molecules induce preferential expansion of CD5C B cells or activated T cells chagasic patients, respectively. Scand J Immunol 51: 91-97.
28. Dutra WO, Gollob KJ 2008. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21: 287-292.
29. Dutra WO, Martins-Filho OA, Cançado JR, Pinto-Dias JC, Brener Z, Freeman Júnior GL, Colley DG, Gazzinelli G, Parra JC 1994. Activated T and B lymphocytes in peripheral blood of patients with Chagas disease. Int Immunol 6: 499-506.
30. Dutra WO, Martins-Filho OA, Cançado JR, Pinto-Dias JC, Brener Z, Gazzinelli G, Carvalho JF, Colley DG 1996. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol 43: 88-93.
31. Elias FE, Vigliano CA, Laguens RP, Levin MJ, Berek C 2003. Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease. Am J Trop Med Hyg 68: 242-247.
32. Ferreira MS, Nishioka S, Silvestre MT, Borges AS, Nunes-Araujo FR, Rocha A 1997. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 25: 1397-1400.
33. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E 2003. Increased plasma levels of tumor necrosis factor- alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98: 407-411.
34. +T cells at heart lesions of human chronic Chagas disease cardiomyopathy. Scand J Immunol 66: 362-371
35. Fuenmayor C, Higuchi ML, Carrasco H, Parada H, Gutierrez P, Aiello V, Palomino S 2005. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. Acta Cardiol 60: 33-67.
36. Furness JB 2000. Types of neurons in the enteric nervous system. J Auton Nerv Syst 81: 87-96.
37. Gaze ST, Dutra WO, Lessa M, Lessa H, Guimarães LH, Jesus AR, Carvalho LP, Machado P, Carvalho EM, Gollob KJ 2006. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol 63: 70-78.
38. Gazzinelli RT, Gazzinelli G, Cançado JR, Cardoso JE, Brener Z, Colley DG 1990. Two models of idiotypic stimulation of T lymphocytes from patients with Chagas disease: correlations with clinical forms of infection. Res Immunol 140: 757-761.
39. Girones N, Cuervo H, Fresno M 2005. T. cruzi-induced molecular mimicry and Chagas' disease. Curr Top Microbiol Immunol 296: 89-123.
40. Gollob KJ, Antonelli LR, Faria DR, Keesen TS, Dutra WO 2008. Immunoregulatory mechanisms and CD4-CD8-(double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology. Int Immunopharmacol 8: 1338-1343.
41. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R 2003. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
42. Guhl F, Jaramillo C, Vallejo GA, Cárdenas A-Arroyo F, Aufderheide A 2000. Chagas disease and human migration. Mem Inst Oswaldo Cruz 95: 553-555.
43. Gurtler RE, Cecere MC, Lauricella MA, Cardinal MV, Kitron U, Cohen JE 2007. Domestic dogs and cats as sources of T. cruzi infection in rural Northwestern Argentina. Parasitology 134: 69-82.
44. Hancock K, Zajac AM, Pung OJ, Elvinger F, Rosypal AC, Lindsay DS 2005. Prevalence of antibodies to T. cruzi in raccoons (Procyon lotor) from an urban area of Northern Virginia. J Parasitol 91: 470-472.
45. Hyland KV, Engman DM 2006. Further thoughts on where we stand on the autoimmunity hypothesis of Chagas disease. Trends Parasitol 22: 101-102.
46. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL 1993. Amplification of a T. cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
47. Kierszenbaum F 2005. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 21: 513-516.
48. Köberle F 1968. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6: 63-116.
49. Lages-Silva E, Ramírez LE, Pedrosa AL, Crema E, da Cunha Galvão LM, Junho Pena SD, Macedo AM, Chiari E 2006. Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas' disease in Brazil. J Clin Microbiol 44: 2167-2171.
50. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL 2004. Frequency of interferon- gamma -producing T cells specific for T. cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909-918.
51. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ 2002. T. cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42: 549-555.
52. Lemos EM, Reis D, Adad SJ, Silva GC, Crema E, Correa-Oliveira R 1998. Decreased CD4(+) circulating T lymphocytes in patients with gastrointestinal Chagas disease. Clin Immunol Immunopathol 88: 150-155.
53. Levy MZ, Bowman NM, Kawai V, Waller LA, Cornejo del Carpio JG, Cordova Benzaquen E 2006. Periurban T. cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis 12: 1345-1352.
54. Menezes CA, Rocha MO, Souza PE, Chaves AC, Gollob KJ, Dutra WO 2004. Phenotypic and functional characteristics of CD28C and CD28K cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 137: 129-138.
55. Morato MJ, Brener Z, Cançado JR, Nunes RM, Chiari E, Gazzinelli G 1986. Cellular immune responses of chagasic patients to antigens derived from different T. cruzi strains and clones. Am J Trop Med Hyg 35: 505-511.
56. Ramasawmy R, Cunha-Neto E, Fae KC, Martello FG, Müller NG, Cavalcanti VL, Ianni B, Mady C, Kalil J, Goldberg AC 2006a. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clin Infect Dis 43: 305-311.
57. Ramasawmy R, Cunha-Neto E, Fae KC, Müller NG, Cavalcanti VL, Drigo SA, Ianni B, Mady C, Kalil J, Goldberg AC 2006b. BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis 193: 1394-1399.
58. Ramasawmy R, Fae KC, Cunha-Neto E, Borba SC, Ianni B, Mady C, Goldberg AC, Kalil J 2008. Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among T. cruzi-infected individuals. Mol Immunol 45: 283-288.
59. Ramasawmy R, Fae KC, Cunha-Neto E, Müller NG, Cavalcanti VL, Ferreira RC, Drigo SA, Ianni B, Mady C, Goldberg AC, Kalil J 2007. Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. J Infect Dis 196: 1836-1843.
60. Rassi A Jr, Rassi A, Rassi SG 2007. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 115: 1101-1108.
61. Reis DD, Gazzinelli RT, Gazzinelli G, Colley DG 1993a. Antibodies to T. cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas disease. J Immunol 150: 1611-1618.
62. Reis DD, Jones EM, Tostes S Jr, Lopes ER, Gazzinelli G, Colley DG, McCurley TL 1993b. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of TNF-α cells and dominance of granzyme AC, CD8C lymphocytes. Am J Trop Med Hyg 48: 637-642.
63. Rocha MO, Teixeira MM, Ribeiro AL 2007. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 5: 727-743.
64. Sosa-Estani S, Segura EL 2006. Etiological treatment in patients infected by T. cruzi: experiences in Argentina. Curr Opin Infect Dis 19: 583-587.
65. Souza PE, Rocha MO, Menezes CA, Coelho JS, Chaves AC, Gollob KJ, Dutra WO 2007. T. cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Infect Immun 75: 1886-1894.
66. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, Gollob KJ, Dutra WO 2004. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 72: 5283-5291.
67. Steindel M, Kramer Pacheco L, Scholl D, Soares M, de Moraes MH, Eger I, Kosmann C, Sincero TC, Stoco PH, Murta SM, de Carvalho-Pinto CJ, Grisard EC 2008. Characterization of T. cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. Diagn Microbiol Infect Dis 60: 25-32.
68. Steinkamp M, Geerling I, Seufferlein T, von Boyen G, Egger B, Grossmann J, Ludwig L, Adler G, Reinshagen M 2003. Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology 124: 1748-1757.
69. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM 2004. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950.
70. Vago AR, Andrade LO, Leite AA, d'Avila Reis D, Macedo AM, Adad SJ, Tostes S Jr, Moreira MC, Filho GB, Pena SD 2000. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol 156: 1805-1809.
71. Vago AR, Macedo AM, Adad SJ, Reis DD, Corrêa-Oliveira R 1996. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet 348: 891-892.
72. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A 2006. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144: 724-734.
73. Vitelli-Avelar DM, Sathler-Avelar R, Massara RL, Borges JD, Lage PS, Lana M, Teixeira-Carvalho A, Dias JC, Elói-Santos SM, Martins-Filho OA 2006. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol 145: 81-92.
74. von Boyen GB, Steinkamp M, Reinshagen M, Schäfer KH, Adler G, Kirsch J 2004. Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 53: 222-228.
75. WHO-World Health Organization 2002. Control of Chagas disease, WHO Technical Report Series 905, Geneva, 109 pp.